NCT00563771View on ClinicalTrials.gov

Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

January 31, 2004

Conditions
Hyperuricemia
Interventions
DRUG

Rasburicase

Trial Locations (1)

Unknown

Sanofi-Aventis, Seoul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY